Administration of Anti-Rabies vaccine stimulates production of neutralizing antibodies by the patient`s immune system. Protective levels of antibodies (of more than 0.5 IU/ml of serum) are seen 7 to 14 days after the initial dose of vaccine (window period). Moreover when the bites are on the head, neck, face & hands, the incubation period will be shorter.
Thus the patients are vulnerable to develop rabies during this window period of 7 to 14 days. RIGs are readymade anti-rabies antibodies and provide passive immunity to rabies.
Following situations need RIG:-
There are two types of RIGs:-
Availability of different RIGs in India:- HRIG Brands
ERIG Brands
Majority of reactions to ERIG result from complement activation and are not IgE mediated and will not be predicted by skin testing.
The recent WHO recommendation states that there are no scientific grounds for performing a skin test prior to the administration of ERIG, because testing does not predict reactions and ERIG should be given whatever the result of the test.
However skin test is mandatory to avoid any possible litigation under consumer protection Act (COPRA) in India.
Inject 0.1 ml ERIG diluted 1:10 in physiological saline intra-dermally into the flexor surface of the forearm to raise a bleb of about 3-4 mm diameter.
Inject an equal amount of normal saline as a negative control on the flexor surface of the other forearm After 15 minutes an increase in diameter to > 10 mm of indurations surrounded by flare is taken as positive skin test, provided the reaction on the saline test was negative.
An increase or abrupt fall in blood pressure, syncope, hurried breathing, palpitations and any other systemic manifestations should be taken as positive test.
A negative skin test must never reassure the physician that no anaphylactic reaction will occur. Those administering ERIG should always be ready to treat early anaphylactic reactions with adrenalin. The dose is 0.5 ml of 0.1 percent solution (1 in 1000, 1mg/ml) for adults and 0.01 ml/kg body weight for children, injected subcutaneously or IM. If patient is sensitive to ERIG, HRIG should be used.
Most ERIGs that are manufactured presently are highly purified and the occurrence of adverse events has been significantly reduced. Unlike the original unpurified rabies antisera which resulted in adverse reactions in as many as 40% of recipients, the adverse-reaction rate of patients receiving highly purified ERIGs has been reduced to <1-2%. However adverse event like anaphylaxis cannot be completely ruled out.
In rare cases the following adverse reactions may occur:
Local reactions:
Anti-sera of equine origin may cause anaphylactic shock and thus sensitivity testing is mandatory before giving ERIG. A negative skin test must never reassure the physician that no anaphylactic reaction will occur.
Management if anaphylactic reaction occurs:
If patient is sensitive to ERIG, HRIG should be used. Patient who had prior exposure of anti-sera (e.g.-Anti-tetanus serum, anti-diphtheria serum) should receive subcutaneous dose of Inj adrenaline (the requirement will be half dose of that required for treatment for anaphylaxis).
Tolerance and side effects:
ERIG should preferably be given in a hospital setting.
It is important to infiltrate all wounds with RIGs. Intra-muscular (IM) administration of RIGs is of very little value. The previous recommendation was to give anti rabies serum half into wounds and half IM, which is no longer recommended and may lead to treatment failure. As much of the calculated dose of RIG, as is anatomically feasible, should be infiltrated into & around all the wounds. In the event that some volume of RIGs is left over after all wounds have been infiltrated, it should be administered by deep IM at a site distant from the vaccine injection site.
If the calculated dose of RIG is insufficient to infiltrate all wounds, sterile saline can be used to dilute it 2 or 3 fold to permit thorough infiltration.
If a person has consumed milk of a rabid animal, counseling should be done. If counseling is not effective, then PrEP by IM or ID route or as a last resort a course of PEP (only vaccine) should be given.
If the milk is boiled or heated then only counseling or at the most a course of PrEP should be given only due to compulsions in medical practice in Indian setting.
Kissing a rabies patient may transmit disease because there may be contact with rabies patient's saliva. Full post-exposure immunization must be given either by Intramuscular (IM) or Intradermal (ID) route.
If there are ulcers in the mouth of the exposed person, then RIGs must be given by IM route.
The clinical course of rabies in animals is divided into three phases:-
However, the signs are variable and the lengths of phases may be irregular.
Vaccinating the pet dog is primarily to protect it against contracting rabies following bites by stray rabid dogs/animals. No veterinary vaccine offers 100% protection against rabies. Rabies is enzootic in our stray animal/dog population. The facility of protective antibody titre test (in vaccinated dog) is available only at a few centers in the country. The facility to quarantine the bitten vaccinated pet is limited and difficult. In view of the above facts and practical realities, rabies being 100% fatal, we take no chances and start PEP (immunization) in the bitten person and presume the vaccinated dog to be incubating rabies (and infective) and simultaneously observe the dog.
However, in extremely rare situations exception to the above thumb rule can be made at the professional discretion of the treating physician.
If a potent veterinary vaccine is given correctly as per pre-exposure schedule, it will mostly prevent rabies in the vaccinated dog, unless the exposure is severe. Ideally, its sera should be tested for protective antibody titre level but this is rarely practicable due to scare facilities in our country. Consequently, PEP vaccination is recommended following bites even by vaccinated dogs. It has been noted that:-
As rabies is enzootic, that is, widely prevalent in stray dogs in India, if unvaccinated pet dog/cat is bitten by a stray dog, the pet may develop rabies and later pose threat at home to all family members.
Dogs effectively vaccinated against rabies ordinarily do not suffer and transmit the disease. But it is very difficult to say with certainty that a particular dog immunized with a specific vaccine is immune against rabies. If a tissue culture vaccine is regularly given to a healthy dog, it should develop sufficient protection. However, following severe and extensive bites (challenge dose of virulent virus infection) by a rabid dog, it may still succumb to rabies.
Ideally, the pet dog should be put to sleep (Euthanasia). The usual method of euthanasia for dogs is by IV injection of either concentrated Magnesium Sulphate solution or concentrated pentabarbitone.
No. Neither the age nor the breed or sex of the dog is important in transmission of rabies.
It is important to establish if the biting animal is healthy or diseased, bearing in mind that a rabid animal excretes the virus in its saliva not just throughout the illness but also several days before the appearance of the first signs. An unknown animal, which has disappeared, must be considered as rabid and full course of PEP must be given. Cats and dogs, which can be identified, must be kept under observation. The risk of rabies can be considered as slight if the animal shows no sign of disease after 5 days, and non-existent if the animal is still healthy on the 10th day (The European Standards recommend an observation period of 15 days).
All wild animals, and those domestic animals suspected of having rabies must be put down and the rabies diagnosis must be carried out in the laboratory.
If it is proven that the animal is not rabid - and only then - the anti-rabies treatment may be halted.
Yes. The rabies virus after multiplying in the brain spreads to other organs of the body like the heart, muscles, skin, etc. So the dog can definitely get infected because the virus can spread through oral mucous membrane.
Following severe and extensive bites which mean injection of very high challenge dose of virulent virus by a rabid dog, a vaccinated dog can still succumb to rabies.
A dog effectively vaccinated against rabies ordinarily will not suffer and transmit rabies. But it is very difficult to say with certainty that a particular dog immunized with specific vaccine is immune against rabies, more so in a rabies-endemic area.
Animal lovers and pet owners are always at high risk of rabies, and therefore, pre-exposure vaccination is recommended for all the family members.
"World Rabies Day" is on 28th September.
Remember, humanizing your dog is fulfilling your own human needs, not your dogs. Humanizing dogs does more harm than good.
Dogs do not sweat through the skin. They exchange most of their heat through the mouth, and extend the tongue to increase the surface exposed to the air.
A rabies patient can make a valid will.
According to Section 59 in the Indian Succession Act, 1925
Person capable of making will:-
Monoclonal antibodies (mAb) are important reagents used in biomedical research, in diagnosis of diseases, and in treatment of such diseases as infections and cancer. These antibodies are produced by cell lines or clones obtained from animals that have been immunized with the substance that is the subject of study. The cell lines are produced by fusing B cells from the immunized animal with myeloma cells.
Monoclonal antibodies against rabies virus have been widely used in the diagnosis and immunological analysis of rabies. Human monoclonal antibodies to rabies virus G protein are also expected to be used as a replacement for rabies immunoglobulin (RIG) in the post-exposure treatment of rabies. In 1978, Wiktor reported the preparation of rabies virus monoclonal antibodies. Since then, rabies virus monoclonal antibody (mAb) technology has been more and more widely used in basic research and diagnosis of rabies.
The Milwaukee protocol is an experimental course of treatment of an acute infection of rabies in a human being. The treatment involves putting the patient into a chemically induced coma and administering antiviral drugs. It was developed and named by Dr. Rodney Willoughby, following the successful treatment of Jeanna Giese, a teenager from Wisconsin who became the first of only six patients known to have survived symptomatic rabies without receiving the rabies vaccine.
Medical history has shown most rabies deaths are caused by temporary brain dysfunction with little to no damage occurring to the brain itself. Using this information, Willoughby's team devised an experimental treatment for rabies. Giese's parents agreed to the experimental treatment. Dr. Willoughby's goal was to put Giese into an induced coma to essentially protect herself from her brain, with the hope she would survive long enough for her immune system to produce the antibodies to fight off the virus. Giese was given a mixture of ketamine and midazolam to suppress brain activity, and the antiviral drugs ribavirin and amantadine, while waiting for her immune system to produce antibodies to attack the virus. Giese was brought out of the coma after six days, once signs of the immune system's progress became apparent. After 31 days in the hospital, Giese was declared virus-free and removed from isolation.The reasons for Giese's survival under the Milwaukee protocol remain controversial.
Recent WHO expert consultation did not recommend this protocol to be tried.
Important rabies websites are:-